tiprankstipranks
Advertisement
Advertisement

PCAIGNO Stock Latest News

Aignostics Highlights Atlas H&E-TME Access for Researchers and Biopharma at AACR 2026
Private CompaniesAignostics Highlights Atlas H&E-TME Access for Researchers and Biopharma at AACR 2026
4h ago
AIGNO
Aignostics Promotes Atlas H&E-TME Access for Academic and Biopharma Users
PremiumPrivate Companies
Aignostics Promotes Atlas H&E-TME Access for Academic and Biopharma Users
10h ago
AIGNO
Aignostics Showcases Atlas for Academics Platform at AACR 2026
PremiumPrivate Companies
Aignostics Showcases Atlas for Academics Platform at AACR 2026
1d ago
AIGNO
Aignostics Showcases Atlas for Academics at AACR 2026 to Deepen Research Engagement
PremiumPrivate Companies
Aignostics Showcases Atlas for Academics at AACR 2026 to Deepen Research Engagement
2d ago
AIGNO
Aignostics Expands AI Pathology Footprint and Showcases Oncology Collaborations at AACR
PremiumPrivate Companies
Aignostics Expands AI Pathology Footprint and Showcases Oncology Collaborations at AACR
5d ago
AIGNO
Aignostics Highlights STEM Outreach and Diversity Efforts With Girls’ Day Event
PremiumPrivate CompaniesAignostics Highlights STEM Outreach and Diversity Efforts With Girls’ Day Event
6d ago
AIGNO
Aignostics Highlights STEM Outreach and Diversity Efforts With Berlin Girls’ Day Event
Premium
Private Companies
Aignostics Highlights STEM Outreach and Diversity Efforts With Berlin Girls’ Day Event
6d ago
AIGNO
Aignostics Showcases Oncology Research Collaborations at AACR 2026
Premium
Private Companies
Aignostics Showcases Oncology Research Collaborations at AACR 2026
6d ago
AIGNO
Aignostics Expands Atlas H&E-TME Cancer Coverage and Targets Academic Researchers
PremiumPrivate Companies
Aignostics Expands Atlas H&E-TME Cancer Coverage and Targets Academic Researchers
7d ago
AIGNO
Aignostics Showcases Oncology Research Collaborations and Spatial Profiling Capabilities at AACR 2026
PremiumPrivate Companies
Aignostics Showcases Oncology Research Collaborations and Spatial Profiling Capabilities at AACR 2026
7d ago
AIGNO
Aignostics Expands AI Pathology Atlas to Additional Cancer Types
PremiumPrivate Companies
Aignostics Expands AI Pathology Atlas to Additional Cancer Types
7d ago
AIGNO
Aignostics Expands Academic Access to AI Tumor Microenvironment Profiling
PremiumPrivate Companies
Aignostics Expands Academic Access to AI Tumor Microenvironment Profiling
9d ago
AIGNO
Aignostics Highlights AI Pathology Advances and Biopharma Collaboration at AACR 2026
PremiumPrivate CompaniesAignostics Highlights AI Pathology Advances and Biopharma Collaboration at AACR 2026
12d ago
AIGNO
Aignostics Showcases AI-Driven Tumor Microenvironment Research at AACR 2026
Premium
Private Companies
Aignostics Showcases AI-Driven Tumor Microenvironment Research at AACR 2026
15d ago
AIGNO
Aignostics Showcases AI Pathology Research at AACR 2026
Premium
Private Companies
Aignostics Showcases AI Pathology Research at AACR 2026
15d ago
AIGNO
Aignostics Uses Women’s Day to Spotlight Imposter Syndrome and Talent Strategy
PremiumPrivate Companies
Aignostics Uses Women’s Day to Spotlight Imposter Syndrome and Talent Strategy
1M ago
AIGNO
Aignostics Highlights Workplace Culture and Imposter Syndrome Focus
PremiumPrivate Companies
Aignostics Highlights Workplace Culture and Imposter Syndrome Focus
1M ago
AIGNO
Aignostics Highlights Workplace Culture and Imposter Syndrome in Talent Strategy
PremiumPrivate Companies
Aignostics Highlights Workplace Culture and Imposter Syndrome in Talent Strategy
1M ago
AIGNO
Aignostics Expands Berlin Hiring to Scale AI-Driven Precision Medicine
PremiumPrivate Companies
Aignostics Expands Berlin Hiring to Scale AI-Driven Precision Medicine
2M ago
AIGNO
Aignostics’ LinkedIn Post Spotlights Atlas 2 Pathology Foundation Model and Clinical Deployment Focus
PremiumPrivate CompaniesAignostics’ LinkedIn Post Spotlights Atlas 2 Pathology Foundation Model and Clinical Deployment Focus
3M ago
AIGNO
Aignostics – Weekly Recap
Premium
Private Companies
Aignostics – Weekly Recap
3M ago
AIGNO
Aignostics Unveils Atlas 2 Pathology Foundation Model, Targets Licensing and Market Expansion
Premium
Private Companies
Aignostics Unveils Atlas 2 Pathology Foundation Model, Targets Licensing and Market Expansion
3M ago
AIGNO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >